Correlation Between Inozyme Pharma and Annexon
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Annexon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Annexon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Annexon, you can compare the effects of market volatilities on Inozyme Pharma and Annexon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Annexon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Annexon.
Diversification Opportunities for Inozyme Pharma and Annexon
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Inozyme and Annexon is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Annexon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexon and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Annexon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexon has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Annexon go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Annexon
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Annexon. In addition to that, Inozyme Pharma is 1.19 times more volatile than Annexon. It trades about -0.69 of its total potential returns per unit of risk. Annexon is currently generating about -0.5 per unit of volatility. If you would invest 757.00 in Annexon on August 28, 2024 and sell it today you would lose (228.00) from holding Annexon or give up 30.12% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Annexon
Performance |
| Timeline |
| Inozyme Pharma |
| Annexon |
Inozyme Pharma and Annexon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Annexon
The main advantage of trading using opposite Inozyme Pharma and Annexon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Annexon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexon will offset losses from the drop in Annexon's long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Annexon vs. Eliem Therapeutics | Annexon vs. Scpharmaceuticals | Annexon vs. Milestone Pharmaceuticals | Annexon vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |